V022-1228 Screening compound: 3-[(4-fluorophenyl)methyl]-5-[4-(4-methoxybenzamido)phenyl]-2-oxo-N-[(oxolan-2-yl)methyl]-1,3-oxazolidine-4-carboxamide

V022-1228 Screening compound: 3-[(4-fluorophenyl)methyl]-5-[4-(4-methoxybenzamido)phenyl]-2-oxo-N-[(oxolan-2-yl)methyl]-1,3-oxazolidine-4-carboxamide
V022-1228 Screening compound: 3-[(4-fluorophenyl)methyl]-5-[4-(4-methoxybenzamido)phenyl]-2-oxo-N-[(oxolan-2-yl)methyl]-1,3-oxazolidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V022-1228
3-[(4-fluorophenyl)methyl]-5-[4-(4-methoxybenzamido)phenyl]-2-oxo-N-[(oxolan-2-yl)methyl]-1,3-oxazolidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V022-1228

Molecular Formula

C30H30FN3O6 (C30 H30 FN3 O6)

Compound Name

3-[(4-fluorophenyl)methyl]-5-[4-(4-methoxybenzamido)phenyl]-2-oxo-N-[(oxolan-2-yl)methyl]-1,3-oxazolidine-4-carboxamide

IUPAC name

3-[(4-fluorophenyl)methyl]-5-[4-(4-methoxybenzamido)phenyl]-2-oxo-N-[(oxolan-2-yl)methyl]-13-oxazolidine-4-carboxamide

SMILES

COc(cc1)ccc1C(Nc1ccc(C(C(C(NCC2OCCC2)=O)N2Cc(cc3)ccc3F)OC2=O)cc1)=O

InChI

InChI=1S/C30H30FN3O6/c1-38-24-14-8-21(9-15-24)28(35)33-23-12-6-20(7-13-23)27-26(29(36)32-17-25-3-2-16-39-25)34(30(37)40-27)18-19-4-10-22(31)11-5-19/h4-15,25-27H,2-3,16-18H2,1H3,(H,32,36)(H,33,35)

InChI Key

VBDPDNWSMCDJBG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19876120

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

547.58

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.293

Distribution Coefficient, logD

3.293

Water Solubility, LogSw

-3.59

Polar Surface Area

87.870

Acid Dissociation Constant (pKa)

11.39

Base Dissociation Constant (pKb)

-0.91

Number of Chiral Centers

3.00

Percent sp3 carbon bonding

30.00

V022-1228 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V022-1228 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V022-1228?
Check Price and Availability of V022-1228, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V022-1228 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V022-1228
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V022-1228
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V022-1228 available by request